Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 11/20 | 0.43 |
| ▸ | PPARG | P37231 | 10/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14184774 | 0.91 | PPARG (0.38) | PPARAPPARGPOLBSIGMAR1CYP1A2 | |
| SCHEMBL11303015 | 0.89 | TSHR (0.46) | PPARAPPARGPOLBTSHR | |
| SCHEMBL11442486 | 0.84 | PPARA (0.44) | PPARAPPARGPOLBSIGMAR1GAA | |
| SCHEMBL8674766 | 0.83 | MAPT (0.44) | PPARAPPARGCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL28687388 | 0.82 | PPARA (0.41) | PPARAPPARGPOLBSIGMAR1CYP1A2 | |
| SCHEMBL31027992 | 0.81 | CA12 (0.48) | PPARAPPARG | |
| SCHEMBL10359315 | 0.81 | ACHE (0.41) | PPARAPPARGTSHRNPSR1 | |
| SCHEMBL11371209 | 0.81 | LTA4H (0.47) | CYP1A2CYP2C9CYP2C19CYP2D6TSHR | |
| SCHEMBL10359839 | 0.81 | PPARG (0.44) | PPARAPPARGPOLBSIGMAR1CYP1A2 | |
| SCHEMBL4258180 | 0.79 | ALDH1A1 (0.43) | PPARAPPARGCYP1A2CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118878399-A | Preparation method and application of crude drug intermediate ether alcohol | 山东润青前线生物科技股份有限公司 | 2024-11-01 | — | — | CN | claimed |
| US-4496440-A | TO ALDEHYDE OR ACID GROUPS | THE DOW CHEMICAL COMPANY (US) | 1985-01-29 | — | — | US | claimed |
| CN-118878399-A | Preparation method and application of crude drug intermediate ether alcohol | 山东润青前线生物科技股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| EP-0391942-A1 | PROCESS FOR THE PREPARATION OF ARYLOXYACETIC ACID | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-10-17 | — | — | EP | disclosed |
| US-4935540-A | OXIDIZING ARYLOXYETHANOL IN PRESENCE OF PALLADIUM AND THALLIU M ON CARBON CATALYST, ACIDIFYING | EASTMAN CHEMICAL COMPANY | 1990-06-19 | — | — | US | disclosed |
| WO-1989003378-A1 | PROCESS FOR THE PREPARATION OF ARYLOXYACETIC ACID | EASTMAN KODAK COMPANY (US) | 1989-04-20 | — | — | WO | disclosed |
| US-4804777-A | OXIDATION OF ARYLOXYETHANOL USING PALLADIUM, SILVER, CARBON CATALYST | EASTMAN KODAK COMPANY (US) | 1989-02-14 | — | — | US | disclosed |
| US-4496440-A | TO ALDEHYDE OR ACID GROUPS | THE DOW CHEMICAL COMPANY (US) | 1985-01-29 | — | — | US | disclosed |
| EP-0011793-B1 | PROCESS FOR PREPARING ARYLOXYACETIC ACIDS | BAYER AG (DE) | 1981-09-02 | — | — | EP | disclosed |
| US-4238625-A | ACTIVATORS OF LEAD AND/OR BISMUTH AND/OR THEIR COMPOUNDS FOR OXIDATION WITH PLATINUM OR PALLADIUM CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-09 | — | — | US | disclosed |
| US-4231781-A | Halophenoxy-alkoxy phosphonates and thiophosphonates | GAF CORPORATION (US) | 1980-11-04 | — | — | US | disclosed |
| EP-0011793-A1 | Process for preparing aryloxyacetic acids | BAYER AG (DE) | 1980-06-11 | — | — | EP | disclosed |
| US-4203757-A | Halophenoxyalkoxy phosphorous-containing sulfides | GAF CORPORATION (US) | 1980-05-20 | — | — | US | disclosed |